Inhibition of nitric oxide synthase activity and chemokine (CXCL12) supplementation can improve hematopoietic reconstitution in mice lethally irradiated by 60Co gamma radiation

Daniel Perez Vieira; Andrés Jimenez Galisteo Jr.; Heitor Franco de Andrade Jr.

doi:10.15392/bjrs.v7i1.789

Authors

Daniel Perez Vieira Instituto de Pesquisas Energéticas e Nucleares - IPEN/CNEN-SP
Andrés Jimenez Galisteo Jr. Institute of Tropical Medicine IMTSP – Laboratory of Protozoology
Heitor Franco de Andrade Jr. Institute of Tropical Medicine IMTSP – Laboratory of Protozoology

DOI:

https://doi.org/10.15392/bjrs.v7i1.789

Keywords:

nitric oxide, CXCL12, hematopoiesis

Abstract

Reduction of nitric oxide (NO) production is related to increased survival in some models of infection and ionizing radiation (IR) exposure. The work used lethally irradiated (⁶⁰Co, 8Gy) C57Bl6j mice, treated or not with aminoguanidine (AG), an inhibitor of an isoform of nitric oxide synthase (iNOS). Also tested iNOS-/- knockout mice and a distinct group treated intraperitoneally with synthetic CXCL12, a homing chemokine related to hematopoietic reconstitution after IR exposures. Aminoguanidine treatment lead to an overshoot of proliferation of hematopoietic CD34⁺ cells in bone marrows (2nd day after IR) and spleens (2nd to 4th day after IR) of irradiated mice, showing a compensative response of these organs against deleterious effects of radiation. CXCL12 mRNA production was increased in spleens of AG-treated mice at 2nd day after IR, but not in other periods neither in bone marrows. CXCL12 administration did not alter CD34⁺ counts but seemed to keep circulating platelet counts in levels comparable to controls. Thus, CXCL12 and AG administration could help on bone marrow repopulation after critically exposed individuals.

Downloads

Download data is not yet available.

References

VEREMEYEVA, G. et al., Long-Term Cellular Effects in Humans Chronically Exposed To Ionizing Radiation, Health Phys. 99 (3) p. 337–346 , 2010.

SINGH, V.K., SEED, T.M., A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures, Int. J. Radiat. Biol. 93 (9) p. 851–869 , 2017.

ASANO, S., Current status of hematopoietic stem cell transplantation for acute radiation syndromes, Int. J. Hematol. 95 (3) p. 227–231 , 2012.

MOJENA, M. et al., Protection against gamma-radiation injury by protein tyrosine phosphatase 1B, Redox Biol. 17 (April) p. 213–223 , 2018.

XIE, J. et al., Graphdiyne Nanoparticles with High Free Radical Scavenging Activity for Radiation Protection, ACS Appl. Mater. Interfaces p. acsami.8b00949 , 2018.

YAMAMOTO, T., KINOSHITA, M., “Radioprotective Effect of Vitamin C as an Antioxidant”, Vitamin C, InTech 450.

MAMBET, C. et al., Murine models based on acute myeloid leukemia-initiating stem cells xenografting., World J. Stem Cells 10 (6) p. 57–65 , 2018.

SHI, Q., SCHATTEN, G., HODARA, V., SIMERLY, C., VANDEBERG, J.L., Endothelial reconstitution by CD34+ progenitors derived from baboon embryonic stem cells, J. Cell. Mol. Med. 17 (2) p. 242–251 , 2013.

PANCH, S.R., SZYMANSKI, J., SAVANI, B.N., STRONCEK, D.F., Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy, Biol. Blood Marrow Transplant. 23 (8) p. 1241–1249 , 2017.

OOSTVOGELS, R. et al., In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: A systematic review, Bone Marrow Transplant. 52 (9) p. 1233–1240 , 2017.

TAY, J., LEVESQUE, J.P., WINKLER, I.G., Cellular players of hematopoietic stem cell mobilization in the bone marrow niche, Int. J. Hematol. 105 (2) p. 129–140 , 2017.

KOLLET, O. et al., Rapid and efficient homing of human CD34+ CD38-/low CXCR4+ stem and progenitor cells to the bone marrow and spleen of NOD / SCID and NOD / SCID / B2m null mice, Blood 97 (10) p. 3283–3291 , 2001.

WU, J. et al., The Differentiation Balance of Bone Marrow Mesenchymal Stem Cells Is Crucial to Hematopoiesis., Stem Cells Int. 2018 p. 1540148 , 2018.

YU, L. et al., Identification and expression of novel isoforms of human stromal cell-derived factor 1, Gene 374 (1-2) p. 174–179 , 2006.

RATAJCZAK, M.Z., ADAMIAK, M., PLONKA, M., ABDEL-LATIF, A., RATAJCZAK, J., Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment - The involvement of extracellular nucleotides and purinergic signaling, Leukemia 32 (5) p. 1116–1123 , 2018.

RATAJCZAK, M.Z., SERWIN, K., SCHNEIDER, G., Innate immunity derived factors as external modulators of the CXCL12 - CXCR4 axis and their role in stem cell homing and mobilization, Theranostics 3 (1) p. 3–10 , 2013.

SANTOS, G.S., TSUTSUMI, S., VIEIRA, D.P., BARTOLINI, P., OKAZAKI, K., Effect of Brazilian propolis (AF-08) on genotoxicity, cytotoxicity and clonogenic death of Chinese hamster ovary (CHO-K1) cells irradiated with 60Co gamma-radiation, Mutat. Res. - Genet. Toxicol. Environ. Mutagen. 762 p. 17–23 , 2014.

MAGALHÃES, V.D. et al., In v itro tests of resveratrol radiomodifying effect on rhabdomyosarcoma cells by comet assay, Toxicol. Vitr. 28 (8) , 2014.

VANNINI, F., KASHFI, K., NATH, N., The dual role of iNOS in cancer, Redox Biol. 6 p. 334–343 , 2015.

DAS, P., LAHIRI, A., LAHIRI, A., CHAKRAVORTTY, D., Modulation of the arginase pathway in the context of microbial pathogenesis: A metabolic enzyme moonlighting as an immune modulator, PLoS Pathog. 6 (6) , 2010.

NAHREVANIAN, H., Involvement of nitric oxide and its up/down stream molecules in the immunity against parasitic infections., Braz. J. Infect. Dis. 13 (6) p. 440–8 , 2009.

IBUKI, Y., GOTO, R., Ionizing radiation-induced macrophage activation: augmentation of nitric oxide production and its significance., Cell. Mol. Biol. (Noisy-le-grand). 50 Online p. OL617–26 , 2004.

LOWENSTEIN, C.J., PADALKO, E., iNOS (NOS2) at a glance, J. Cell Sci. 117 (14) p. 2865–2867 , 2004.

HANAUE, N. et al., Peroxynitrite formation in radiation-induced salivary gland dysfunction in mice., Biomed. Res. 28 (3) p. 147–51 , 2007.

YANG, Y. et al., Nitric oxide synthase inhibitors: a review of patents from 2011 to the present, Expert Opin. Ther. Pat. p. 1–20 , 2014.

CHOI, B., PAE, H., JANG, S. Il, KIM, Y., CHUNG, H., Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator., J. Biochem. Mol. Biol. 35 (1) p. 116–26 , 2002.

ZHANG, S.-Y. et al., NF-kappaB decoy potentiates the effects of radiation on vascular smooth muscle cells by enhancing apoptosis., Exp. Mol. Med. 37 (1) p. 18–26 , 2005.

HE, W., FROST, M.C., CellNO trap: Novel device for quantitative, real-time, direct measurement of nitric oxide from cultured RAW 267.4 macrophages, Redox Biol. 8 p. 383–397 , 2016.

GARNICA, M.R., SILVA, J.S., DE ANDRADE JUNIOR, H.F., Stromal cell-derived factor-1 production by spleen cells is affected by nitric oxide in protective immunity against blood-stage Plasmodium chabaudi CR in C57BL/6j mice, Immunol. Lett. 89 (2-3) p. 133–142 , 2003.

GRATAMA, J., ORFAO, A., BARNETT, D., BRANDO, B., Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells, Cytometry 34 (December 1997) p. 128–142 , 1998.

SHAO, L., LUO, Y., ZHOU, D., Hematopoietic Stem Cell Injury Induced by Ionizing Radiation, Antioxid. Redox Signal. 20 (9) p. 1447–1462 , 2014.

NIKOLIC, T., DINGJAN, G.M., LEENEN, P.J.M., HENDRIKS, R.W., A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics., Eur. J. Immunol. 32 (3) p. 686–92 , 2002.

NEMZEK, J.A., BOLGOS, G.L., WILLIAMS, B.A., REMICK, D.G., Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling site, Inflamm. Res. 50 p. 523–527 , 2001.

ASTOLFI, R.S., KHOURI, D.G., BRANDIZZI, L.I.V., ÁVILA-CAMPOS, M.J., ANDRADE JR., H.F. de, Antagonic effect of the inhibition of inducible nitric oxide on the mortality of mice acutely infected with Escherichia coli and Bacteroides fragilis, Brazilian J. Med. Biol. Res. 40 (3) p. 317–322 , 2007.

GARNICA, M.R., SOUTO, J.T., SILVA, J.S., DE ANDRADE, H.F., Stromal cell derived factor 1 synthesis by spleen cells in rodent malaria, and the effects of in vivo supplementation of SDF-1alpha and CXCR4 receptor blocker., Immunol. Lett. 83 (1) p. 47–53 , 2002.

BASTIANUTTO, C. et al., Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow, Cancer Res. 67 (21) p. 10112–10116 , 2007.

HÉRODIN, F., BOURIN, P., MAYOL, J.F., LATAILLADE, J.J., DROUET, M., Short-term injection of antiapoptotic cytokine combinations soon after lethal γ-irradiation promotes survival, Blood 101 (7) p. 2609–2616 , 2003.

LATAILLADE, J.-J., Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G0/G1 transition in CD34+ cells: evidence for an autocrine/paracrine mechanism, Blood 99 (4) p. 1117–1129 , 2002.

LAPIDOT, T., DAR, A., KOLLET, O., How do stem cells nd their way home?, Blood 106 (6) p. 1901–1910 , 2005.

DOMINICI, M. et al., Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation, 114 (11) p. 2333–2343 , 2011.

HILDEBRANDT, G. et al., Mechanisms of the anti-inflammatory activity of low-dose radiation therapy., Int. J. Radiat. Biol. 74 (3) p. 367–78 , 1998.

SOUTHAN, G.J., SZABÓ, C., Selective pharmacological inhibition of distinct nitric oxide synthase isoforms, Biochem. Pharmacol. 51 (4) p. 383–394 , 1996.